Inventor · disambiguated record
Nicholas Kelly
Also filed as: KELLY NICHOLAS · KELLY NICHOLAS M · KELLY NICHOLAS MICHAEL
11 granted patents·7 pending applications·106 citations·filing 2002–2020
88Inventor score
Top patents by PatentIndex Score
18 records- 0194US6951849B2Benzimidazolidinone derivatives as muscarinic agentsACADIA PHARM INC·Filed 2003·Granted Oct 4, 2005·44 cites·21 claims
- 0292US10959942B2Animal feed compositions and uses thereofNOVOZYMES AS·Filed 2016·Granted Mar 30, 2021·7 cites·12 claims
- 0391US7087593B2Benzimidazolidinone derivatives as muscarinic agentsACADIA PHARM INC·Filed 2002·Granted Aug 8, 2006·34 cites·19 claims
- 0489US7300928B2Benzimidazolidinone derivatives as muscarinic agentsACADIA PHARM INC·Filed 2006·Granted Nov 27, 2007·7 cites·21 claims
- 0588US7291611B2Benzimidazolidinone derivatives as muscarinic agentsACADIA PHARM INC·Filed 2005·Granted Nov 6, 2007·6 cites·23 claims
- 0685US7273857B2Benzimidazolidinone derivatives as muscarinic agentsACADIA PHARM INC·Filed 2006·Granted Sep 25, 2007·6 cites·9 claims
- 0778US11730714B2Compounds for the treatment of neuromuscular disordersNMD PHARMA AS·Filed 2018·Granted Aug 22, 2023·2 cites·20 claims
- 0864US2008070948A1Benzimidazolidinone derivatives as muscarinic agentsACADIA PHARM INC·Filed 2007·Application pending·0 cites
- 0963US2008009520A1Benzimidazolidinone derivatives as muscarinic agentsACADIA PHARM INC·Filed 2007·Application pending·0 cites
- 1060US12440477B2Compounds for the treatment of neuromuscular disordersNMD PHARMA AS·Filed 2018·Granted Oct 14, 2025·0 cites·24 claims
- 1160US2006258707A1Benzimidazolidinone derivatives as muscarinic agentsKELLY NICHOLAS M·Filed 2006·Application pending·0 cites
- 1254US2010216840A1Benzimidazolidinone derivatives as muscarinic agentsACADIA PHARM INC·Filed 2010·Application pending·0 cites
- 1347US12221425B2Process for the preparation of CIC-1 chloride channel inhibitorsNMD PHARMA AS·Filed 2020·Granted Feb 11, 2025·0 cites·22 claims
- 1446US12415771B2Compounds for the treatment of neuromuscular disordersNMD PHARMA AS·Filed 2020·Granted Sep 16, 2025·0 cites·19 claims
- 1546US2005136444A1Treating neuropathic pain with neuropeptide FF receptor 2 agonistsFiled 2004·Application pending·0 cites
- 1641US12168643B2Compounds for the treatment of neuromuscular disordersNMD PHARMA AS·Filed 2020·Granted Dec 17, 2024·0 cites·20 claims
- 1738US2019183812A1Compounds For The Treatment Of Neuromuscular DisordersNMD PHARMA AS·Filed 2018·Application pending·0 cites
- 1834US2006217370A1Compounds useful for the treatment and prevention of pain and screening methods thereforBURSTEIN ETHAN·Filed 2006·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Nicholas Kelly files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →